Page 70 - Depression in adults: treatment and management
P. 70
Depression in adults: treatment and management (NG222)
• discussing the risks and benefits with the person or, if appropriate, their advocate or
carer. [2022] [2022]
1.13.6 Clinics should only provide ECT if they:
• are Electroconvulsive Therapy Accreditation Service (ECTAS) accredited
• provide ECT services in accordance with ECTAS standards
• submit data, including outcomes, on each course of acute and maintenance ECT they
deliver as needed for the ECTAS minimum dataset.
Follow the ECT Accreditation Service Standards for Administering ECT. [2022] [2022]
1.13.7 Trusts which provide ECT services should ensure compliance with the ECTAS
standards for administering ECT through board-level performance
management. [2022] [2022]
1.13.8 Stop ECT treatment for a person with depression:
• immediately, if the side effects outweigh the potential benefits, or or
• when stable remission has been achieved. [2022] [2022]
1.13.9 If a person's depression has responded to a course of ECT:
• start (or continue) antidepressant medication or a psychological intervention to
prevent relapse and to provide ongoing care for their depression (see the
recommendations on preventing relapse)
• consider lithium augmentation of antidepressant medication (see the
recommendations on further-line treatment). [2022] [2022]
For a short explanation of why the committee made these recommendations and how they
might affect practice, see the rationale and impact section on further-line treatment.
Full details of the evidence and the committee's discussion are in evidence review D: further-
line treatment.
© NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 70 of
conditions#notice-of-rights). 103